KO vs XOM: Which Is the Better Buy?

Side-by-side comparison of The Coca-Cola Company and Exxon Mobil Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-19.
The Coca-Cola Company Β· Consumer Defensive
$88.71
+15.5% upside to fair value
Med Conviction Grade C High Quality
VS
Exxon Mobil Corporation Β· Energy
$163.18
+10.3% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
KO has more upside to fair value (+15.5%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric KO XOM
Current Price $88.71 $163.18
Fair Value Estimate $102.44 $179.98
Upside to Fair Value +15.5% +10.3%
Market Cap $381.7B $676.3B
Forward P/E β€” β€”
EV / EBITDA 20.8x 9.9x
Price / Sales 7.6x 1.9x
Price / FCF 26.7x 22.3x
Revenue Growth YoY +6.7% +44.1%
Gross Margin 61.9% 25.1%
Operating Margin 29.6% 10.7%
Return on Equity 43.0% 12.7%
Dividend Yield 2.37% 2.52%
FCF Yield 3.75% 4.49%
Analyst Consensus Strong Buy Hold
Investment Thesis
KO β€” The Coca-Cola Company
The Coca-Cola Company is a global non-alcoholic beverage concentrate, brand-management and bottling-system business with products sold in more than 200 countries and territories, supported by powerful trademarks, 2.2 billion daily servings and an entrenched distribution network. Business quality is high: TTM gross, operating and net margins are 61.9%, 29.6% and 28.6%, respectively, ROE is 43.0%, …
XOM β€” Exxon Mobil Corporation
Exxon Mobil is the largest integrated oil and gas major in the United States, operating across Upstream exploration and production, Downstream refining and fuels marketing, and Chemical manufacturing, with roughly 57,900 employees and a portfolio that spans conventional crude and natural gas, LNG, petrochemicals, and early-stage carbon capture, hydrogen, and biofuels ventures. The business qualit…
Accumulation Zones
Metric KO XOM
Zone Low $76.83 $134.98
Zone High $87.07 $152.98
In Buy Zone? No No
← KO Research    XOM Research β†’    All Research